BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 10185455)

  • 1. The impact of pharmaceutical direct advertising: opportunities and obstructions.
    Pinto MB; Pinto JK; Barber JC
    Health Mark Q; 1998; 15(4):89-101. PubMed ID: 10185455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dialogue. Prescription for problems? Capitating mental health drugs--the great debate.
    Docherty JP; Browne RA; Farmer M
    Behav Healthc Tomorrow; 1998 Oct; 7(5):32-8. PubMed ID: 10185199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health plans keeping drug cost increases in check with programs that promote generics.
    Capitation Manag Rep; 2002 Jul; 9(7):101-3, 97. PubMed ID: 12164057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct-to-consumer advertising affects provider / patient relationship.
    Contracept Technol Update; 1998 Dec; 19(12):153-5. PubMed ID: 12321805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct-to-consumer ads can influence behavior. Advertising increases consumer knowledge and prescription drug requests.
    Peyrot M; Alperstein NM; Van Doren D; Poli LG
    Mark Health Serv; 1998; 18(2):26-32. PubMed ID: 10180332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The economics of direct-to-consumer advertising of prescription-only drugs: prescribed to improve consumer welfare?
    Morgan S; Mintzes B; Barer M
    J Health Serv Res Policy; 2003 Oct; 8(4):237-44. PubMed ID: 14596759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promotion of prescription drugs to consumers.
    Rosenthal MB; Berndt ER; Donohue JM; Frank RG; Epstein AM
    N Engl J Med; 2002 Feb; 346(7):498-505. PubMed ID: 11844852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marketplace. Managed care plans try to cope as drug ads spur patient demand.
    Moskowitz DB
    Med Health; 1998 May; 52(20):suppl 1-2. PubMed ID: 10179010
    [No Abstract]   [Full Text] [Related]  

  • 9. Managing prescription drug costs.
    Sica JM
    Empl Benefits J; 2001 Mar; 26(1):35-40. PubMed ID: 11272515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefit and risk information in prescription drug advertising: review of empirical studies and marketing implications.
    Kopp SW; Bang HK
    Health Mark Q; 2000; 17(3):39-56. PubMed ID: 11010219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The true cost of membership acquisition in Medicare risk.
    Klitsch J
    Health Care Strateg Manage; 1997 Jul; 15(7):1, 20, 22-3. PubMed ID: 10168424
    [No Abstract]   [Full Text] [Related]  

  • 12. Marketing drugs: debating the real cost. Concern about close ties between doctors and pharmaceutical firms are prompting new financial disclosure laws and education efforts.
    Brand R
    State Legis; 2008 Sep; 34(8):26-9. PubMed ID: 18754159
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of drug reimportation on managed care pharmacy.
    Penna P
    Manag Care Interface; 2003 Jul; 16(7):41-2. PubMed ID: 12908216
    [No Abstract]   [Full Text] [Related]  

  • 14. The price of seduction: direct-to-consumer advertising of prescription drugs in the US.
    Marks JH
    N C Med J; 2003; 64(6):292-5. PubMed ID: 14983622
    [No Abstract]   [Full Text] [Related]  

  • 15. Prescription drug advertising: is it a driving force on drug pricing?
    Millstein LG
    N C Med J; 2003; 64(6):289-91. PubMed ID: 14983621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marketing pharmaceutical products to physicians. Sales reps influence physicians' impressions of the industry.
    Creyer EH; Hrsistodoulakis I
    Mark Health Serv; 1998; 18(2):34-8. PubMed ID: 10180333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A wonderful life or diarrhea and dry mouth? Policy issues of direct-to-consumer drug advertising on television.
    Macias W; Pashupati K; Lewis LS
    Health Commun; 2007; 22(3):241-52. PubMed ID: 17967146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicine goes Madison Avenue: an evaluation of the effect of direct-to-consumer pharmaceutical advertising on the learned intermediary doctrine.
    Allen MC
    Spec Law Dig Health Care Law; 1998 Dec; (236):9-29. PubMed ID: 10187553
    [No Abstract]   [Full Text] [Related]  

  • 19. Can e-prescribing reduce drug costs under capitation?
    Capitation Manag Rep; 2002 Apr; 9(4):58-62, 49. PubMed ID: 12004737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practicing pathology as a health care contractor. Business planning for managed care.
    Elevitch FR
    Arch Pathol Lab Med; 1995 Jul; 119(7):612-7; discussion 617-8. PubMed ID: 7625902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.